3 min
What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer GRACEcast Lung Cancer Video
-
- Science
"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).
"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).
3 min
Top Podcasts In Science
More by GRACEcast
GRACEcast Cancer 101 Video
cancerGRACE - H. Jack West, MD
GRACEcast Head and Neck Cancer Video NEW
cancerGRACE - H. Jack West, MD
GRACEcast Bladder Cancer Video
cancerGRACE - H. Jack West, MD
GRACEcast Cancer 101 Audio
cancerGRACE - H. Jack West, MD
GRACEcast Kidney Cancer Video
cancerGRACE - H. Jack West, MD
GRACEcast Pancreatic Cancer Video
cancerGRACE - H. Jack West, MD